Caregivers can budget for dementia prescription costs by planning around Medicare's $2,100 annual out-of-pocket cap for covered Part D drugs in 2026, spreading payments through the Medicare Prescription Payment Plan, and checking Extra Help and formulary coverage. Part D is Medicare's coverage for prescription drugs normally picked up at a pharmacy.
Routine pills and high-cost infusions follow different rules. According to the Centers for Medicare & Medicaid Services, the Part D cap applies to covered drugs, then the plan pays 100% of covered drug costs for the rest of the year Medicare prescription payment information. Premiums, non-covered drugs, and Part B infusion coinsurance fall outside that cap.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does the Part D cap cover?
- How can monthly billing help cash flow?
- Who can get Extra Help with copays?
- What should infusion budgets include?
- How can generic choices lower pharmacy bills?
What does the Part D cap cover?
The cap limits what a caregiver must plan for covered retail drugs. Once out-of-pocket spending on covered Part D drugs reaches $2,100 in 2026, the plan covers those drugs for the remainder of the year. That creates a clear annual ceiling for covered prescriptions.
The ceiling does not include monthly premiums. It also does not cover drugs that are off-formulary or otherwise not covered. Caregivers should check the plan's drug list before assuming a prescription counts toward the cap.
How can monthly billing help cash flow?
High drug costs often arrive unevenly, especially early in the year. The Medicare Prescription Payment Plan lets caregivers turn Part D out-of-pocket costs into monthly bills.
According to the Centers for Medicare & Medicaid Services, the option has no fees or interest details on monthly prescription billing. The plan changes timing, not the total owed. It works best when caregivers join early and track monthly statements.
- Ask the Part D plan about joining before costly refills begin
- Expect separate bills for premiums and non-covered drugs
- Keep receipts for pharmacy, plan, and Extra Help records
Who can get Extra Help with copays?
Medicare Extra Help reduces costs for people with limited income and resources. It pays Part D premiums, eliminates the deductible, and limits copays for covered drugs.
Medical News Today reports 2025 copays of about $4.90 for generics and $12.15 for brands, with $0 after total drug costs reach $2,000 guide to Extra Help costs. That support can sharply lower the monthly cost of long-term dementia prescriptions. Caregivers can apply through Social Security and ask the Part D plan how Extra Help changes each refill price.
What should infusion budgets include?
Leqembi is an infused Alzheimer treatment covered under Part B, not Part D. The Centers for Medicare & Medicaid Services covers it only for enrolled beneficiaries with mild cognitive impairment or mild dementia plus documented amyloid, when the clinician reports data to an approved registry. Infusion visits, scans, and monitoring add to the yearly budget.
Original Medicare beneficiaries generally owe 20% Part B coinsurance after meeting the Part B deductible. Costs differ for people with Medigap, secondary insurance, or Medicare Advantage. Caregivers should ask both the clinic and the plan for a written estimate.
How can generic choices lower pharmacy bills?
Older oral dementia drugs often have low-cost generic versions. Brand Aricept can cost about $500 for 30 days, while generic donepezil ranges from $9 to $60 by pharmacy, according to Medical News Today comparison of Aricept and donepezil prices.
Generics usually sit on a lower formulary tier with a smaller copay. List prices for newer infused drugs are much higher: Leqembi carries a $26,500 annual list price, while Kisunla is priced at about $32,000 for 12 months and is designed to stop after amyloid clearance. Ask the prescriber whether a generic is appropriate, compare pharmacies, and confirm the selected drug is on the plan formulary.
